{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:00:15Z","timestamp":1790316015764,"version":"4.1.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The gut microbiota can alter drug metabolism, efficacy, and toxicity, while medications can reciprocally reshape microbial communities. However, the structure and maturation of research specifically addressing these bidirectional interactions have not been comprehensively mapped.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Web of Science Core Collection (WoSCC) was the sole source for bibliometric mapping because it provides standardized cited-reference metadata. PubMed was used only for complementary search-strategy validation. We analyzed 9,242 English-language articles and reviews published from 2003 through 2025 using VOSviewer, CiteSpace, and bibliometrix. A seeded random sample of 100 WoSCC records was assessed at title\/abstract level to evaluate search specificity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The 9,242-publication corpus showed sustained growth, reaching 2,160 publications in 2025. For descriptive comparison, the study period was divided\n                      <jats:italic>a priori<\/jats:italic>\n                      into foundational discovery (2003\u20132013), translational acceleration (2014\u20132020), and rapid expansion (2021\u20132025); these intervals were not statistically estimated change points. Keyword co-occurrence yielded five clusters: pharmacomicrobiomics\/drug metabolism, microbiota\u2013immune oncology, metabolic disease, gastrointestinal\/inflammatory disorders, and the gut\u2013brain axis. Thematic and burst analyses additionally highlighted natural products, network pharmacology, immunotherapy, and microbiota-directed interventions as recent or rapidly developing topics. In the 100-record specificity audit, 82 records were directly relevant at title\/abstract level.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This large-scale bibliometric analysis maps the development of gut microbiota\u2013drug interaction research while distinguishing established clusters from topics identified as recent frontiers. The findings support growing translational interest but should not be interpreted as evidence of clinical efficacy or research quality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1957920","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:33:42Z","timestamp":1790314422000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global research trends and emerging frontiers of gut microbiota\u2013drug interactions: a bibliometric and visualization analysis (2003\u20132025)"],"prefix":"10.3389","volume":"17","author":[{"given":"Yingxian","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Lung Cancer Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxi","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, West China Hospital, Sichuan University","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Lung Cancer Center, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"ref2","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.joi.2017.08.007","article-title":"Bibliometrix: an R-tool for comprehensive science mapping analysis","volume":"11","author":"Aria","year":"2017","journal-title":"J. Informetr."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/1389200223666220128141038","article-title":"Gut microbiota as the potential mechanism to mediate drug metabolism under high-altitude hypoxia","volume":"23","author":"Bai","year":"2022","journal-title":"Curr. Drug Metab."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/asi.20317","article-title":"CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature","volume":"57","author":"Chen","year":"2006","journal-title":"J. Am. Soc. Inf. Sci. Technol."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.4155\/fmc-2020-0023","article-title":"The central role of gut microbiota in drug metabolism and personalized medicine","volume":"12","author":"Colotti","year":"2020","journal-title":"Future Med. Chem."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1124\/dmd.121.000669","article-title":"Exploring drug metabolism by the gut microbiota: modes of metabolism and experimental approaches","volume":"50","author":"Dhurjad","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e22350","DOI":"10.1096\/fj.202101986R","article-title":"Pharmacomicrobiomics: influence of gut microbiota on drug and xenobiotic metabolism","volume":"36","author":"Dikeocha","year":"2022","journal-title":"FASEB J."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ebiom.2019.05.009","article-title":"Bringing microbiome-drug interaction research into the clinic","volume":"44","author":"Guthrie","year":"2019","journal-title":"EBioMedicine"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"ofad195","DOI":"10.1093\/ofid\/ofad195","article-title":"Principles and terminology for host-microbiome-drug interactions","volume":"10","author":"Heirali","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/gutjnl-2020-321031","article-title":"Ginseng polysaccharides alter the gut microbiota and kynurenine\/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1\/programmed cell death ligand 1 (anti-PD-1\/PD-L1) immunotherapy","volume":"71","author":"Huang","year":"2022","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1517\/17425255.2013.807798","article-title":"The effect of gut microbiota on drug metabolism","volume":"9","author":"Kang","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1517\/17425255.2016.1121234","article-title":"The influence of gut microbiota on drug metabolism and toxicity","volume":"12","author":"Li","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.adk7633","article-title":"Bespoke plant glycoconjugates for gut microbiota-mediated drug targeting","volume":"388","author":"Ma","year":"2025","journal-title":"Science"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3389\/fphar.2020.01153","article-title":"NSAID-gut microbiota interactions","volume":"11","author":"Maseda","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1053\/j.gastro.2022.06.070","article-title":"Population-level metagenomics uncovers distinct effects of multiple medications on the human gut microbiome","volume":"163","author":"Nagata","year":"2022","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00248-022-02081-x","article-title":"Human gut microbiota and drug metabolism","volume":"86","author":"Pant","year":"2023","journal-title":"Microb. Ecol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature11450","article-title":"A metagenome-wide association study of gut microbiota in type 2 diabetes","volume":"490","author":"Qin","year":"2012","journal-title":"Nature"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"114902","DOI":"10.1016\/j.addr.2023.114902","article-title":"Targeting microbiome, drug metabolism, and drug delivery in oncology","volume":"199","author":"Sumiyoshi","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1124\/dmd.115.065714","article-title":"Drug metabolism by the host and gut microbiota: a partnership or rivalry?","volume":"43","author":"Swanson","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s13318-023-00874-0","article-title":"Novel techniques and models for studying the role of the gut microbiota in drug metabolism","volume":"49","author":"Tan","year":"2024","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","article-title":"Mapping human microbiome drug metabolism by gut bacteria and their genes","volume":"570","author":"Zimmermann","year":"2019","journal-title":"Nature"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"goac009","DOI":"10.1093\/gastro\/goac009","article-title":"Interplays between drugs and the gut microbiome","volume":"10","author":"Wan","year":"2022","journal-title":"Gastroenterol. Rep. (Oxf.)"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1126\/science.aad1329","article-title":"Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota","volume":"350","author":"V\u00e9tizou","year":"2015","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-023-01619-w","article-title":"Drug-microbiota interactions: an emerging priority for precision medicine","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/19490976.2019.1667724","article-title":"Insights from pharmacokinetic models of host-microbiome drug metabolism","volume":"11","author":"Zimmermann-Kogadeeva","year":"2020","journal-title":"Gut Microbes"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e2207366","DOI":"10.1002\/advs.202207366","article-title":"A review of gut microbiota-derived metabolites in tumor progression and cancer therapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci (Weinh)."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1834916","DOI":"10.3389\/fmed.2026.1834916","article-title":"Associations between prevalent unhealthy lifestyles and the gut microbiota: a comprehensive multi-database bibliometric analysis of pathogenic mechanisms and clinical trajectories","volume":"13","author":"Zhou","year":"2026","journal-title":"Front. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1957920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:33:43Z","timestamp":1790314423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1957920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":38,"alternative-id":["10.3389\/fmicb.2026.1957920"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1957920","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"article-number":"1957920"}}